Ex vivo evolution of human antibodies by CRISPR-X: from a naive B cell repertoire to affinity matured antibodies - Inserm - Institut national de la santé et de la recherche médicale Access content directly
Journal Articles BMC Biotechnology Year : 2019

Ex vivo evolution of human antibodies by CRISPR-X: from a naive B cell repertoire to affinity matured antibodies

Abstract

Methodology article

Domains

Cancer Genetics
Fichier principal
Vignette du fichier
DevilderEq1_2019.pdf (1.9 Mo) Télécharger le fichier
Origin : Publication funded by an institution
Loading...

Dates and versions

inserm-02117156 , version 1 (02-05-2019)

Identifiers

Cite

Marie-Claire Devilder, Melinda Moyon, Laetitia Gautreau-Rolland, Benjamin Navet, Jeanne Perroteau, et al.. Ex vivo evolution of human antibodies by CRISPR-X: from a naive B cell repertoire to affinity matured antibodies. BMC Biotechnology, 2019, 19 (1), ⟨10.1186/s12896-019-0504-z⟩. ⟨inserm-02117156⟩
103 View
111 Download

Altmetric

Share

Gmail Facebook X LinkedIn More